0409-1465Level 3
Nalbuphine Hydrochloride (NALBUPHINE HYDROCHLORIDE)
**Product type:** Human Prescription Drug
**Active ingredient:** NALBUPHINE HYDROCHLORIDE
**Strength:** 20 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular; Intravenous; Subcutaneous
**Labeler:** Hospira, Inc.
**Marketing category:** ANDA (ANDA070916)
**Pharmacologic class:** Competitive Opioid Antagonists [MoA], Opioid Agonist/Antagonist [EPC], Partial Opioid Agonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0409-1465Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.